Picture of Medexus Pharmaceuticals logo

MDP Medexus Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Brief: Medexus Q3 Revenue Up 35%

Feb 8 (Reuters) - Medexus Pharmaceuticals Inc  MDP.TO :
    * MEDEXUS PHARMACEUTICALS INC Q3 REVENUE ROSE 35 PERCENT TO
$28.7
MILLION
    * MEDEXUS ANNOUNCES ANOTHER RECORD QUARTER WITH FISCAL Q3
2023
REVENUE OF US$28.7 MILLION, A 35% INCREASE OVER FISCAL Q3 2022
    * MEDEXUS PHARMACEUTICALS INC QTRLY NET LOSS OF $1.5
MILLION, A
YEAR-OVER-YEAR CHANGE OF $0.4 MILLION

Source text for Eikon:  ID:nGNX18lCR5 
Further company coverage:  MDP.TO 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Medexus Pharmaceuticals

See all news